BD's Q1 Earnings Call: Our Top 5 Analyst Questions
Is now the time to buy BDX? Find out in our full research report (it's free).
Revenue: $5.27 billion vs analyst estimates of $5.35 billion (4.5% year-on-year growth, 1.5% miss)
Adjusted EPS: $3.35 vs analyst estimates of $3.28 (2.1% beat)
Adjusted EBITDA: $1.52 billion vs analyst estimates of $1.54 billion (28.9% margin, 1.1% miss)
Adjusted EPS guidance for the full year is $14.20 at the midpoint, missing analyst estimates by 1.2%
Operating Margin: 10.4%, down from 14.5% in the same quarter last year
Constant Currency Revenue rose 6% year on year (4.7% in the same quarter last year)
Market Capitalization: $48.98 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Larry Biegelsen (Wells Fargo) asked for clarity on the magnitude and mitigation of tariff expenses, with CFO Chris DelOrefice explaining that the $0.25 per share impact is net of mitigation efforts and would need to be partially annualized for next year.
Robbie Marcus (JPMorgan) pressed on specific drivers behind the downward revision in organic growth, with DelOrefice breaking down the headwinds as primarily stemming from China, research spending cuts, and slow diagnostic recovery.
Matt Taylor (Jefferies) explored the company's levers for managing tariffs, prompting CEO Tom Polen to detail inventory repositioning, supplier shifts, and the use of alternate global manufacturing sites to reduce exposure.
Travis Steed (Bank of America) questioned the credibility of the accelerated growth outlook for the second half, with management conceding that macro volatility has made guidance more difficult but expressing confidence in the pipeline of launches and operational execution.
Patrick Wood (Morgan Stanley) asked about sustaining internal efficiency programs, to which Polen and President Mike Feld highlighted that the BD Excellence initiatives are still expanding and viewed as energizing for employees, freeing up time for value-added work.
In the coming quarters, the StockStory team will be monitoring (1) the pace of recovery in diagnostics and research funding environments, (2) successful ramp-up and market uptake of new product launches such as FACSDiscover A8 and CentroVena One, and (3) the effectiveness of tariff mitigation strategies as the external landscape evolves. Execution on the planned business separation and further margin improvements through BD Excellence will also be key signposts.
BD currently trades at $170.90, down from $206.90 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Wells Fargo completes long-planned sale of its downtown Des Moines buildings
After a more than 2 1/2-year effort to concentrate its Des Moines metro employees on its West Des Moines campus, Wells Fargo has finally sold off the office complex that once was among the largest owned by a corporation in downtown Des Moines. Records filed with the Polk County Recorders Office on Monday, Aug. 18, show that DMCRE1 LLC, with a mailing address in Grand Island, Nebraska, has acquired the seven parcels for $36 million. Public documents also show Bankers Trust Company as the mortgage holder in the transaction, at $19.5 million. The documents list Gordon Glade of Grand Island, Nebraska, as the representative for DMCRE1. The price was less than two-thirds of the assessed valuation of the properties. City records show the sale of the buildings, comprising more than 850,000 square feet of floorspace, was agreed to in December. They had been on the market since early 2023. Glade did not respond to a telephone call from the Des Moines Register seeking comment. A spokesman for Wells Fargo declined to comment on the sale. Plans filed with the city in April call for converting one of the buildings, an 11-story, 188,679-square foot structure built in 1988, into a 170-room hotel with a top-story restaurant. A second, three-story building with 53,668 square feet of floorspace, located at 207 Ninth St. and dating from 1910, would be converted into meeting and office space and a spa with ground-level parking. The buildings are valued at $958,100 and $1.1 million, respectively. The document lists the hotel as a JdV by Hyatt boutique property. It provides no timeline for the conversion. Wells Fargo previously indicated it would lease back some of the space it was selling to house functions that will remain downtown. Those still housed in the city center include its legal department and a division that helps retailers provide consumer credit for major purchases such as furniture and appliances. In addition to the buildings at 206 Eighth and 207 Ninth sts., the transaction includes: 801 Walnut St., a 10-story, 298,882 square foot building constructed in 2005 with an assessed value of $36.7 million. 800 Walnut St., a nine-story, 326,495 square foot building constructed in 2002 with an assessed value of $5.8 million. 800 Mulberry St., an eight-story, 545,238 square-foot parking garage built in 2002 and with an assessed value $9.8 million. 80 Eighth St., a 1.8-acre lot assessed at $865,100. 900 Vine St., a 3.3-acre lot assessed at $1.2 million. The total tax assessed value of the properties is $56.3 million for about 1.4 million square feet of developed space including the parking garage. Des Moines City Council cleared the way for the sale by terminating incentive agreements it reached with Wells Fargo for the 800 and 801 Walnut St. buildings and the parking garage. In an interview with the Des Moines Business Record, Glade indicated that only 800 Walnut St. would be available for resale. Wells Fargo also has sold a major office building on Westown Parkway in West Des Moines as it moved most of its offices to the 157-acre campus at 800 S. Jordan Creek Parkway, also in West Des Moines. It is assessed at nearly $196 million, according to the Dallas County Assessor's website. It also let lapse naming rights for the downtown arena that is Iowa's largest, now Casey's Center, that it had held for 20 years. Once the Des Moines metro's largest employer, Wells Fargo has shed more than 1,000 jobs in more than 80 announced layoffs since April 2022. Kevin Baskins covers jobs and the economy for the Des Moines Register. Reach him at kbaskins@ This article originally appeared on Des Moines Register: Wells Fargo sells downtown Des Moines properties
Yahoo
10 hours ago
- Yahoo
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?
With a market cap of $56.2 billion, Becton, Dickinson and Company (BDX) is a global medical technology leader that develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products. Headquartered in Franklin Lakes, New Jersey, BD serves healthcare institutions, life science researchers, and the pharmaceutical industry worldwide. Shares of the medical device manufacturer have underperformed the broader market over the past 52 weeks. BDX stock has decreased 16.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.1%. Moreover, shares of the company have declined 13.4% on a YTD basis, compared to SPX's 9.6% rise. More News from Barchart Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Billionaire Philippe Laffont Just Ditched Super Micro Computer Stock. Should You? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Looking closer, the medical device manufacturer stock has also lagged behind the Health Care Select Sector SPDR Fund's (XLV) 10.5% drop over the past 52 weeks. Shares of Becton Dickinson climbed 8.9% on Aug. 7 after the company reported stronger-than-expected Q3 2025 results, with adjusted EPS of $3.68 and revenue of $5.5 billion. Growth was driven by a 14.4% increase in sales from its medical unit to $2.93 billion, slightly topping forecasts, as demand for drug-delivery devices remained strong. Additionally, BD raised its 2025 adjusted profit forecast to a range of $14.30 per share - $14.45 per share. For the fiscal year ending in September 2025, analysts expect BDX's adjusted EPS to grow 9.1% year-over-year to $14.33. The company's earnings surprise history is promising. It beat the consensus estimates in the last four quarters. Among the 18 analysts covering the stock, the consensus rating is a 'Moderate Buy.' That's based on seven 'Strong Buy' ratings, one 'Moderate Buy,' and 10 'Holds.' This configuration is slightly less bullish than three months ago, with eight 'Strong Buy' ratings on the stock. On Aug. 11, Morgan Stanley raised its price target on Becton Dickinson to $197 and maintained an 'Overweight' rating. As of writing, the stock is trading below the mean price target of $216.21. The Street-high price target of $285 implies a potential upside of 45.4% from the current price levels. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Yahoo
Former Wells Fargo Advisors Employee Alleges Discrimination in New Lawsuit
You can find original article here Wealthmanagement. Subscribe to our free daily Wealthmanagement newsletter. A former Wells Fargo Advisors employee is suing the firm and questioning whether her ethnicity and gender played a role in her termination. Lisa Krugler originally filed suit against Wells Fargo Advisors in July in Kentucky state court, but the case was transferred to federal jurisdiction last week. According to the complaint, Krugler joined WFA as a client services associate around May 2021, where she was tasked with helping advisors generate documents, run office responsibilities and process estates. According to the suit, she was adopted from South Korea and grew up in the United States. According to LinkedIn, Krugler worked for Cullinan Associates for eight years before moving to Wells Fargo. The suit noted that she was the only non-white Wells Fargo team member in her location and had consistently met performance review expectations. Krugler said she served as 'primary support' for three advisors, backed up other associates working with eight advisors, and helped handle office tasks. Krugler argued she had the highest workload of anyone in the office. Krugler purportedly asked for a raise in January of this year, and while she was assigned more work, she didn't get a pay bump. According to the complaint, Krugler's supervisor, Chris Bohnert, 'was observed to treat the women in the office differently' than the men, frequently ignoring female coworkers altogether. Krugler found it challenging to take time off, as she often had to do the work of multiple associates. However, according to the suit, she traveled to Disney World in June to celebrate her son's birthday. On the trip's third day, Krugler got a call from Bohnert, which surprised her because WFA prohibits work during paid time off. 'Believing it must be important, Mrs. Krugler answered the phone,' the complaint read. 'Mr. Bohnert began the call by stating, 'I'm glad you're at the happiest place on Earth, because I have to let you go.'' According to the suit, Krugler was 'shocked by the callousness and lack of professionalism' on the call, and asked Bohnert to call back with a third-party witness to the conversation; Bohnert allegedly said he would, but Krugler never received that call. According to Krugler, she was never given a 'satisfactory answer' for her firing. 'When she asked if her status as a Korean woman was the reason she was terminated, Mr. Bohnert responded, 'I don't know. It's nothing personal,'' the complaint read. In the complaint, Krugler argued she was treated 'less favorably than similarly situated White men in the office,' with the person taking over her role having less experience on the team and in the industry altogether. According to a Wells Fargo spokesperson, the firm denied the allegations and "intend to defend the company's position through the litigation process." Krugler asked for damages for 'the humiliation, embarrassment, personal indignity, apprehension about past, current and future well-being, emotional distress, and mental anguish' allegedly caused by the firing, as well as additional relief, 'including reinstatement.'
